Previous 10 | Next 10 |
Exact Sciences (NASDAQ: EXAS ) initiated with Outperform rating and $70 (25% upside) price target at Evercore ISI. More news on: Exact Sciences Corporation, Health Catalyst, Inc., Intercept Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. Stealth BioTherapeutics Corp (NASDAQ: MITO) Q4 2019 Earnings Call Apr 1, 2020 , 8:30 a.m. ET Operator Continue reading
Stealth BioTherapeutics Corp (MITO) Q4 2019 Earnings Conference Call April 01, 2020 08:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Rob Weiskopf - Chief Financial Officer Jim Carr - Chief Clinical Development Officer ...
Stealth BioTherapeutics (NASDAQ: MITO ): FY GAAP EPS of -$0.19. More news on: Stealth BioTherapeutics Corp, Earnings news and commentary, Healthcare stocks news, , Read more ...
BOSTON , April 1, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today reported financial resu...
BOSTON , March 30, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will...
BOSTON , Feb. 27, 2020 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy , CE...
Gainers: QUAD +21.6% . ENPH +10.4% . MITO +5.7% . HLF +5.1% . SCPL +4.7% . More news on: Quad/Graphics, Inc., Enphase Energy, Inc., Stealth BioTherapeutics Corp, Stocks on the move, , , News on ETFs Read more ...
Bellerophon Therapeutics (NASDAQ: BLPH ) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis. More news on: Bellerophon Therape...
5 Penny Stocks To Watch This Week When it comes to penny stocks , the right mix of risk and reward needs to be taken into consideration. All too often, novice traders and investors treat these cheap stocks like lottery tickets. In actuality, they are investments like any other. One of the big...
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...